Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

INVO Bioscience Inc INVO

Healthcare Medical Devices
INVO Bioscience, Inc. is a healthcare services fertility company. The Company is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. The Company’s flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its technique, designated as IVC, provides patients a more connected and intimate experience at a more affordable cost in comparison to in vitro fertilization (IVF), the other advanced ART treatment. Its commercialization strategy is focused on the opening of INVO Centers offering the INVOcell and IVC procedure and the acquisition of existing IVF clinics. The Company operates three INVO Centers in North America.


NDAQ:INVO - Post by User

INVO Bioscience Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(98)
•••
Post by whytestockson Apr 17, 2024 11:15am
31 Views
Post# 35993775

INVO Bioscience Inc. (NASDAQ: INVO) is One of Wednesday Morn

INVO Bioscience Inc. (NASDAQ: INVO) is One of Wednesday Morn
BREAKING NEWS: $INVO INVO Bioscience Inc. (NASDAQ: INVO) is One of Wednesday Morning's Most Active StocksINVO Bioscience, Inc. (NASDAQ: INVO) is one today's most active stocks by volume. So far today, approximately 117.5M shares of INVO Bioscience, Inc. have been exchanged, as compared to an average 30-day volume of 25,386 shares. INVO Bioscience, Inc., a commercial-stage fertility company, provi...INVO - INVO Bioscience Inc. (NASDAQ: INVO) is One of Wednesday Morning's Most Active Stocks

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities